Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26 by U. S. Government Accountability Office (

Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26 (Paperback) (ISBN-13: 9781289123109)

Vendor: U. S. Government Accountability Office (
Product type: Books
Format: Paperback
$17.75
$17.75
$17.75
Subtotal: $17.75
Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26 by U. S. Government Accountability Office (

Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26

$17.75
Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26 by U. S. Government Accountability Office (

Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld Until the Mastitis Issue Is Resolved: Pemd-92-26

$17.75
Format: Paperback
Description
Description
x
The U.S. Government Accountability Office (GAO) is an independent agency that works for Congress. The GAO watches over Congress, and investigates how the federal government spends taxpayers dollars. The Comptroller General of the United States is the leader of the GAO, and is appointed to a 15-year term by the U.S. President. The GAO wants to support Congress, while at the same time doing right by the citizens of the United States. They audit, investigate, perform analyses, issue legal decisions and report anything that the government is doing. This is one of their reports.

Author: U. S. Government Accountability Office (
ISBN-10: 1289123101
ISBN-13: 9781289123109
Publisher: Bibliogov
Language: English
Published: 06/27/2013
Pages: 72
Format: Paperback
Weight: 0.32lbs
Size: 9.69h x 7.44w x 0.15d

Recently Viewed Products